Key statistics dashboard for Achieve Life Sciences, Inc. (ACHV). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom.
Stock Data
| Price | $7.42 |
| Market Cap | $762M |
| Beta | 1.96 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -4.72 |
| Price / Book | -46.64 |
| P/S | 0.00 |
| P/FCF | -15.98 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Current Ratio | 0.95 |
| Quick Ratio | 0.95 |
| Cash Ratio | 0.24 |
| Debt / Equity | -1.02 |
| Debt / Assets | 7.85% |
| Interest Coverage | -58.63 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | -0.16 |
| Cash per share | 2.00 |
| FCF per share | -0.50 |
| Tangible Book Value per share | -0.17 |
| Dividend per share | 0.00 |
Related companies: ALLO · ARCT · AVIR · CAPR · HUMA · IMRX · SGMT
Explore sector: Healthcare · Biotechnology
More sections of ACHV: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks